amphiphilic penetration-enhancement molecule + cisplatin (Intensity Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameamphiphilic penetration-enhancement molecule + cisplatin (Intensity Therapeutics)
Drug Alias NameINT-2238
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntensity Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntensity Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A